Enter at least 4 characters

2 results showing for: 'lenalidomide (viatris)'

- Lenalidomide Viatris: Brand switch fee payable.
- Special Authority SA2353 [PDF]
-- Retail pharmacy
  • Cap 5 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673525
    • Subsidy $76.92
    • Measure / Qty per 21
  • Cap 10 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673533
    • Subsidy $50.30
    • Measure / Qty per 21
  • Cap 15 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673541
    • Subsidy $62.13
    • Measure / Qty per 21
  • Cap 25 mg
    • Brand Fully subsidised brand. Lenalidomide Viatris
    • Pharmacode2673568
    • Subsidy $65.09
    • Measure / Qty per 21
  • 3 to 6 month supply. Brand switch fee
    • Brand Fully subsidised brand. BSF Noumed Phenobarbitone
    • Pharmacode2684756
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Eltroxin
    • Pharmacode2689251
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Pomolide
    • Pharmacode2689278
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Lenalidomide (Viatris)
    • Pharmacode2689286
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Alyacen
    • Pharmacode2692112
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Norethinderone – CDC
    • Pharmacode2692120
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (standalo
    • Pharmacode2692139
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (interope
    • Pharmacode2692147
    • Subsidy $4.50
    • Measure / Qty per 1
    (BSF Noumed Phenobarbitone Brand switch fee to be delisted 01 November 2024)
    (BSF Eltroxin Brand switch fee to be delisted 01 December 2024)
    (BSF Pomolide Brand switch fee to be delisted 01 December 2024)
    (BSF Lenalidomide (Viatris) Brand switch fee to be delisted 01 December 2024)
    (BSF Alyacen Brand switch fee to be delisted 01 January 2025)
    (BSF Norethinderone – CDC Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (standalo Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (interope Brand switch fee to be delisted 01 January 2025)

    May only be claimed once per patient.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply